Corticosteroids as therapeutic agents in liver diseases
Novick, D.M.
American Journal of Gastroenterology 86(1): 30-32
1991
ISSN/ISBN: 0002-9270 PMID: 1986550 Document Number: 375771
Document emailed within 1 workday
Related Documents
Uribe, M.; Ramos, M.H. 1983: Corticosteroids and the liver. Metabolism and indications in liver diseases Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 35(1): 71-80Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Nemeth, A.; Strandvik, B.; Dahlström, K.A.; Eleborg, L.; Blomqvist, B.; Barkholt, L.; Duraj, F.; Ericzon, B.G.; Groth, C.G. 1992: Liver transplantation--a successful therapeutic method for children with severe non-malignant liver diseases Lakartidningen 89(16): 1387-1390
Grompe, M. 1999: Therapeutic liver repopulation for the treatment of metabolic liver diseases Human Cell 12(4): 171-180
Lewis, N.J. 1985: The design and development of therapeutic agents for neuromuscular diseases Progress in Clinical and Biological Research 197: 105-110
Fujitani, Y. 2013: Strategy for research development of therapeutic agents for autoimmune diseases Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 57
Tafreshi, M.J.; Weinacker, A.B. 1999: Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma PharmacoTherapy 19(8): 974-978
Okabe, K.; Fujisawa, K.; Takahashi, T. 1970: Therapeutic agents for lipid metabolism disorders--with special reference to fatty liver Nihon Rinsho. Japanese Journal of Clinical Medicine 28: Suppl: 700-3
Lumholtz, I.B. 1979: Drug information: agents for the treatment of gynecologic diseases. Therapeutic main group: gonadotropins, human chorionic gonadotropin (HCG) Sygeplejersken 79(30): 25
Bauch, K.; Büttner, W.; Lewicki, I.; Zimmermann, S.; Dempe, A. 1973: Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 28(11 Suppl): 169-172
Pokrovskaia, G.R. 1977: Therapeutic diet in diseases of the liver and bile ducts Meditsinskaia Sestra 36(2): 37-40
Maccá, F.; Gatta, A.; Caregaro, L.; Lauro, S.; Milani, L.; Zuin, R.; Menozzi, L. 1982: Therapeutic use of ornithine-carbamyl-transferase in liver diseases Minerva Dietologica E Gastroenterologica 28(1): 71-78
Crouzel, G.; Miani, J.A.; Zelasco, J.F. 1971: Liver diseases and potassium. A new therapeutic approach. Preliminary report Prensa Medica Argentina 58(23): 1201-1206
Bakulenko, E.F. 1976: Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis Vrachebnoe Delo 4: 108-110
Frenk, S. 1974: 25 year's therapeutic use of corticosteroids Gaceta Medica de Mexico 108(2): 93-94
Lagrue, G.; Bariéty, J. 1970: Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents) Münchener Medizinische Wochenschrift 112(12): 515-522
Ohata, K.; Kohno, S. 1987: Progress of therapeutic agents for asthma--3) Trends in the development of leukotriene inhibitory agents Nihon Rinsho. Japanese Journal of Clinical Medicine 45(8): 1843-1852
Resić, H. 2002: Remission of nephrotic syndrome in patients treated with corticosteroids and other immunosuppressive agents Medicinski Arhiv 56(2): 85-88
Bondy, P.K. 1980: Prolonged therapeutic use of corticosteroids. Indications and risks Recenti Progressi in Medicina 69(5): 531-550
Panja, S.K. 1990: Therapeutic update of eczema and topical corticosteroids Indian Journal of Dermatology 35(1): 1-15